Cross-national comparison of prenatal methamphetamine exposure on infant and early child physical growth: a natural experiment. 2014.

A systematic review and meta-analysis of the association between poor oral health and substance abuse. 2017.

Use of Silk Road, the online drug marketplace, in the United Kingdom, Australia and the United States. 2014.

Committee on Substance Abuse, Committee on Fetus and Newborn. Prenatal substance abuse: short- and long-term effects on the exposed fetus. 2013.

Breen C, Awbery E, Burns L Supporting pregnant women who use alcohol or other drugs: a review of the evidence.Canberra: National Drug and Alcohol Research Centre; 2014

Alcohol, methamphetamine, and marijuana exposure have distinct effects on the human placenta. 2016.

Transfer of methamphetamine (MA) into breast milk and urine of postpartum women who smoked MA tablets during pregnancy. 2016.

Maternal use of methadone and risk of sudden neonatal death. 2015.

Advising mothers on the use of medications during breastfeeding: a need for a positive attitude. 2016.

Degenhardt L, Larney S, Chan G Estimating the number of regular and dependent methamphetamine users in Australia, 2002-2014. Med J Aust. 2016; 204:(4)

Effects of prenatal methamphetamine exposure on behavioural and cognitive findings at 7.5 years of age. 2014.

Socially disadvantaged women's views of barriers to feeling safe to engage in decision-making in maternity care. 2014.

Geraghty S Reaching out: caring for women prisoners in Western Australia. Pract Midwife. 2015; 18:(1)26-8

Prenatal and postpartum care of women with substance use disorders. 2014.

Gorman MC, Orme KS, Nguyen NT, Kent EJ, Caughey AB Outcomes in pregnancies complicated by methamphetamine use. Am J Obstet Gynecol. 2014; 211:(4)e1-7

Kezelman C Trauma-informed care and practice in nursing. Australian Nursing and Midwifery Journal. 2016; 24:(2)

Addiction in maternity: prevalence of mental illness, substance use, and trauma. 2013.

Marcellus L Supporting women with substance use issues: trauma-informed care as a foundation for practice in the NICU. Neonatal Network. 2014; 33:(6)307-14

McDonnell-Dowling K, Kelly JP Sources of variation in the design of preclinical studies assessing the effects of amphetamine-type stimulants in pregnancy and lactation. Behavioural Brain Research. 2015; 279:87-99

McLaurin R, Geraghty S Placenta praevia, placental abruption and amphetamine use in pregnancy: A case study. Women Birth. 2013; 26:(2)138-42

Mills KL The importance of providing trauma-informed care in alcohol and other drug services. Drug Alcohol Rev. 2015; 34:(3)231-3

Olsen A, Banwell C, Madden A Contraception, punishment and women who use drugs. BMC Womens Health. 2014; 14:(1)

Pajulo H, Pajulo M, Jussila H, Ekholm E Substance-abusing pregnant women: prenatal intervention using ultrasound consultation and mentalization to enhance the mother-child relationship and reduce substance use. Infant Ment Health J. 2016; 37:(4)317-34

Pedersen W, Sandberg S, Copes H High speed: amphetamine use in the context of conventional culture. Deviant Behav. 2015; 36:(2)146-65

Rausgaard NLK, Ibsen IO, Jørgensen JS, Lamont RF, Ravn P Prevalence of substance abuse in pregnancy among Danish women. Acta Obstet Gynecol Scand. 2015; 94:(2)215-9

Taylor L, Hutchinson D, Rapee R, Burns L, Stephens C, Haber PS Clinical features and correlates of outcomes for high-risk, marginalized mothers and newborn infants engaged with a specialist perinatal and family drug health service. Obstet Gynecol Int. 2012; 2012:1-8

Viteri OA, Soto EE, Bahado-Singh RO, Christensen CW, Chauhan SP, Sibai BM Fetal anomalies and long-term effects associated with substance abuse in pregnancy: a literature review. Am J Perinatol. 2015; 32:(5)405-16

Whiteford HA, Degenhardt L, Rehm J Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010. Lancet. 2013; 382:(9904)1575-86

Wingo AP, Ressler KJ, Bradley B Resilience characteristics mitigate tendency for harmful alcohol and illicit drug use in adults with a history of childhood abuse: a cross-sectional study of 2024 inner-city men and women. Journal of Psychiatric Research. 2014; 51:93-9

Wright TE, Schuetter R, Fombonne E, Stephenson J, Haning WF Implementation and evaluation of a harm-reduction model for clinical care of substance using pregnant women. Harm Reduct J. 2012; 9:(1)

Amphetamine use in pregnancy: Perinatal approaches to improve maternal and neonatal outcomes

02 September 2017
Volume 25 · Issue 9


As the rates of amphetamine use continue to rise, so do the significant social and health implications associated with substance abuse in communities. This presents unique challenges for women, newborns and providers of perinatal care. This article aims to explore amphetamine use among women of childbearing age, and the subsequent effects on the woman and fetus/newborn. The complexity of these cases require a collaborative, woman-centred and multidisciplinary approach, in addition to specialised interventions and adjustments regarding routine antenatal, intrapartum and postnatal plans of care

Amphetamines are highly addictive, relatively low in cost and are easily procured (Pedersen et al, 2015). Amphetamines, and the issues associated with their use, have overtaken other classes of illicit drugs since the 1990s, with the majority of female users being of childbearing age (McDonnell-Dowling and Kelly, 2015). The UK, Australia and the USA have all recorded high rates of amphetamine use (Barratt et al, 2014). Degenhardt et al (2016) have estimated that between 2013 and 2014 there were 268 000 regular users of amphetamines in Australia aged between 15-54 years of age, and 160 000 had a high level of dependency. The sharp increase in the prevalence of amphetamine use globally will require particular consideration in the planning and allocation of future health care resources. This includes maternity services, as the majority of women who use amphetamines are of childbearing age. Pregnancies associated with amphetamine use are considered to be complex and pose an increased risk of complications occurring, which may have significant health implications for both the woman and fetus/newborn (Gorman et al, 2014). It is important to note that women using amphetamines often already have suboptimal health associated with substance abuse, including periodontal issues, poor nutrition and mental health issues (Baghaie et al, 2017), and are often members of marginalised groups with complex psychosocial issues, and a history of reduced rates of health care access and attendance (Whiteford et al, 2013).

Register now to continue reading

Thank you for visiting British Journal of Midwifery and reading some of our peer-reviewed resources for midwives. To read more, please register today. You’ll enjoy the following great benefits:

What's included

  • Limited access to our clinical or professional articles

  • New content and clinical newsletter updates each month